Panic disorder is a mental health condition characterized by recurrent, unexpected panic attacks followed by persistent concern about additional attacks, their consequences, or changes in behavior intended to prevent them. A panic attack is an abrupt surge of intense fear or discomfort accompanied by physical and cognitive symptoms, such as a racing heart, breathlessness, dizziness, and fear of dying or losing control. Attacks can occur in many psychiatric and medical contexts; experiencing one does not, by itself, establish panic disorder.
The condition is important because its symptoms can resemble acute cardiopulmonary illness, while fear of recurrence can substantially restrict travel, employment, education, and social activity. Some affected people develop agoraphobia, in which situations become feared because escape might be difficult or help unavailable. Panic disorder reflects interacting biological vulnerabilities, interpretations of bodily sensations, and learned patterns of avoidance rather than a single identifiable abnormality. Its classification, clinical assessment, and treatment distinguish the immediate experience of panic from the longer-lasting disorder organized around it.
Historical Development and Diagnostic Classification
Descriptions resembling panic attacks long predate the modern diagnosis. In the nineteenth century, physicians described syndromes involving palpitations, breathlessness, chest discomfort, and apprehension, sometimes under cardiovascular or military labels. Jacob Mendes Da Costa’s 1871 account of “irritable heart” in soldiers is an important historical example, although that syndrome cannot be equated directly with present-day panic disorder. Such descriptions included heterogeneous conditions that modern medicine would separate into psychiatric, cardiovascular, respiratory, and other categories.
In 1895, Sigmund Freud distinguished “anxiety neurosis” from the broader contemporary category of neurasthenia. His account included acute anxiety episodes and somatic symptoms, but its explanatory framework differed substantially from current diagnostic practice. A more direct precursor to the modern distinction emerged through twentieth-century clinical research separating abrupt panic episodes from chronic, generalized apprehension. Donald Klein’s work in the 1960s, including observations concerning the effects of imipramine, helped establish panic attacks as a clinically meaningful focus of investigation.
The third edition of the Diagnostic and Statistical Manual of Mental Disorders, published in 1980, recognized panic disorder as a separate diagnosis. Subsequent editions revised its relationship with agoraphobia and refined the requirements concerning persistent concern and behavioral change. Earlier classifications often treated agoraphobia as a complication or subtype of panic disorder. DSM-5, published in 2013, classified panic disorder and agoraphobia separately, allowing either diagnosis to occur without the other. DSM-5-TR, published in 2022, retains that separation.
The International Classification of Diseases also recognizes panic disorder. In ICD-10, it appears under code F41.0, with “episodic paroxysmal anxiety” as an alternative description. In ICD-11, panic disorder is coded 6B01 within anxiety or fear-related disorders. Although classification systems differ in wording and organization, both distinguish recurrent unexpected panic from anxiety that occurs only in relation to a particular feared situation.
These historical changes matter when interpreting older research. Studies of “agoraphobia with panic attacks,” “anxiety neurosis,” and modern panic disorder do not necessarily describe equivalent populations. Apparent changes in frequency, treatment response, or outcome can partly reflect changes in diagnostic boundaries. Contemporary classification also recognizes panic attacks outside panic disorder, including attacks associated with other anxiety conditions, mood disorders, substance effects, and medical illnesses.
Clinical Features and the Experience of an Attack
A panic attack typically begins abruptly and reaches its peak within minutes. Under DSM-5-TR criteria, a full panic attack involves at least four of thirteen symptoms: palpitations or accelerated heart rate; sweating; trembling; shortness of breath; a choking sensation; chest pain or discomfort; nausea or abdominal distress; dizziness, unsteadiness, light-headedness, or faintness; chills or heat sensations; numbness or tingling; derealization or depersonalization; fear of losing control or “going crazy”; and fear of dying. Episodes with fewer symptoms can still be distressing but do not meet that full symptom threshold.
Physical and psychological symptoms reinforce one another. Palpitations may be interpreted as evidence of an impending heart attack, while breathlessness may be interpreted as suffocation. Derealization refers to a feeling that the surroundings are unreal or unfamiliar; depersonalization describes detachment from oneself. These experiences can intensify fear without indicating psychosis or an actual loss of contact with reality. Not every attack contains all these features, and the dominant symptoms can vary between episodes.
“Unexpected” means that no clear immediate cue is apparent at the time of the attack. It does not mean that the episode has no physiological or psychological antecedents. An attack can arise during an otherwise ordinary activity, during relaxation, or from sleep. Nocturnal panic involves awakening in a state of panic and is distinct from a frightening dream, although sleep-related conditions can produce similar experiences. People with panic disorder may also experience expected attacks in settings that have become associated with previous episodes.
The most intense phase is often brief, but the entire episode need not end within a fixed number of minutes. Residual apprehension, exhaustion, or repeated surges can continue after the peak. Conversely, a prolonged period of fluctuating anxiety is not necessarily one continuous panic attack. The clinical distinction depends on the abrupt escalation and characteristic symptom cluster rather than duration alone.
Between attacks, anticipatory anxiety may become more disabling than the attacks themselves. A person may repeatedly monitor heart rate, avoid physical exertion, travel only with a companion, or remain close to exits. These behaviors can initially reduce distress while progressively limiting daily activity. Panic disorder therefore involves more than episodic fear: it includes persistent changes in attention, expectation, and behavior. Attacks occurring exclusively in response to a specific feared object or situation, without independent unexpected attacks, generally point toward another diagnostic formulation.
Epidemiology, Onset, and Risk Factors
Estimates of panic disorder vary with the population, interview method, diagnostic criteria, and period measured. In the United States National Comorbidity Survey Replication, conducted in 2001–2003, estimated lifetime prevalence among adults was approximately 4.7%, and twelve-month prevalence was approximately 2.7%. These figures are not universal rates. Cross-national studies generally report lower average estimates and substantial variation among countries. Panic attacks themselves are considerably more common than panic disorder because many people experience isolated or situational attacks without developing persistent concern or avoidance.
The condition commonly begins in late adolescence or early adulthood, although onset can occur outside that period. Childhood presentations are less common, and diagnosis can be complicated by developmental differences in how bodily sensations and fears are described. New panic-like symptoms in later life require particularly careful interpretation because cardiovascular, respiratory, neurological, medication-related, and other medical explanations become increasingly relevant. Older age does not exclude panic disorder, but age at onset contributes to the diagnostic context.
Women are diagnosed more often than men, with many population studies finding a roughly twofold difference. Biological, psychological, and social factors may all contribute, and differences in symptom reporting and help-seeking can affect measured rates. The sex distribution does not imply that attacks in men are unusual or clinically different in all respects. Research findings based mainly on treatment-seeking samples may not reproduce the distribution found in community surveys.
Family and twin studies support a heritable contribution, but inheritance is not deterministic. Twin-based heritability estimates have commonly been around 40%, with variation across methods and samples. This is a population-level estimate of variation in liability under particular conditions, not a statement that a fixed percentage of an individual’s disorder is genetic. Familial patterns can also reflect shared environments, learned responses to bodily symptoms, and overlapping vulnerability to other anxiety conditions.
Reported risk correlates include an inhibited or anxiety-prone temperament, heightened fear of anxiety sensations, childhood adversity, stressful life events, and family histories of anxiety disorders. Smoking is associated with panic-related outcomes in observational research, although causal pathways are complex and may involve respiratory sensations, nicotine effects, withdrawal, and shared vulnerabilities. Social disadvantage and barriers to care can influence persistence and disability. These associations identify patterns across groups; none is necessary or sufficient for diagnosis, and many affected people do not report an obvious precipitating event.
Biological and Psychological Mechanisms
Panic disorder is understood through interacting systems for detecting threat, regulating bodily states, interpreting internal sensations, and learning from experience. No single brain region or chemical disturbance explains all cases. Activity within the sympathetic nervous system can produce increased heart rate, sweating, and trembling. Changes in breathing can contribute to dizziness, tingling, and chest discomfort. These responses are genuine physiological events, even when the feared catastrophe does not occur.
Research on the brain implicates networks involving the amygdala, insula, hippocampus, prefrontal regions of the cerebral cortex, and brainstem structures involved in arousal and respiratory regulation. The amygdala contributes to threat processing, the insula to the representation of internal bodily states, and the hippocampus to contextual memory. These functions are not exclusive to panic disorder. Findings from imaging studies vary, and group differences do not constitute a diagnostic brain scan for an individual.
Respiratory and chemosensory models have been influential. In laboratory studies, carbon dioxide inhalation and sodium lactate infusion can provoke panic more readily in some people with panic disorder than in comparison groups. Donald Klein’s “false suffocation alarm” hypothesis proposed that panic could reflect inappropriate activation of a system sensitive to suffocation-related signals. Such experiments demonstrate vulnerability to particular bodily challenges, but they do not establish a single cause or provide routine diagnostic tests. Hyperventilation can contribute to symptoms, but not all attacks begin with it.
Cognitive models emphasize the interpretation of bodily sensations. In David Clark’s influential 1986 formulation, a benign sensation such as a faster heartbeat can be misinterpreted as imminent catastrophe. Fear then increases arousal, producing stronger sensations that appear to confirm the original interpretation. Anxiety sensitivity—the tendency to fear anxiety-related sensations because of their anticipated consequences—helps explain why similar physical changes can be tolerable for one person and alarming for another. Interoception, the sensing and interpretation of internal bodily signals, is central to this account.
Learning processes help explain persistence. Internal sensations or external settings associated with an attack can become conditioned warning signals. Avoidance then reduces fear in the short term, reinforcing the avoidance itself. Safety behaviors, such as relying on a particular companion or continually checking bodily signs, may prevent learning that the feared outcome would not occur without them. Biological and cognitive accounts are therefore complementary: bodily fluctuations provide signals, interpretations shape their meaning, and learning influences future responses.
Diagnostic Assessment and Differential Diagnosis
The diagnosis is clinical and depends on the pattern of attacks and their aftermath. DSM-5-TR requires recurrent unexpected panic attacks, with at least one attack followed by one month or more of persistent concern about additional attacks or their consequences, or a significant maladaptive change in behavior related to the attacks. Symptoms must not be attributable to a substance, medication, or another medical condition, and must not be better explained by another mental disorder. Recurrent attacks without the persistent concern or behavioral component do not automatically meet these criteria.
Assessment includes the timing, frequency, triggers, symptoms, and consequences of episodes. A medical history addresses medication use, stimulants, alcohol and other substances, sleep, prior illness, and family history. The physical examination and any investigations depend on the presentation rather than a universal panic-disorder test panel. Clinicians also examine avoidance, functional impairment, depressive symptoms, substance use, and suicidal thoughts. The Panic Disorder Severity Scale is one established measure for tracking severity, but a rating scale does not replace diagnostic assessment.
The differential diagnosis includes conditions capable of producing overlapping autonomic or respiratory symptoms. Examples include cardiac arrhythmias, hyperthyroidism, hypoglycemia, asthma, and some seizure disorders. Acute conditions such as myocardial infarction and pulmonary embolism can also resemble aspects of panic. A previous diagnosis of panic disorder does not establish that every subsequent episode of chest pain or breathlessness has the same cause. Testing is directed by clinical findings and the likelihood of particular alternatives.
Substance-related presentations require attention to both intoxication and withdrawal. Caffeine and other stimulants can provoke anxiety and panic-like symptoms, while withdrawal from alcohol or sedative drugs can cause marked autonomic arousal. Medication effects, including those of some respiratory and stimulant medicines, may also contribute. A substance-induced syndrome is distinguished by its relationship to exposure or withdrawal, although substance use and independent panic disorder can coexist.
Among psychiatric alternatives, social anxiety disorder usually involves fear of scrutiny, specific phobias involve circumscribed feared situations, and post-traumatic stress disorder may involve attacks linked to trauma reminders. Obsessive-compulsive disorder can produce acute fear in response to intrusive thoughts or feared consequences. Agoraphobia is assessed separately rather than assumed from the presence of panic. Cultural interpretations and local idioms of distress also affect how symptoms are described, making the meaning and context of an episode important alongside its symptom count.
Psychological Treatments and Their Evidence Base
Cognitive behavioral therapy is one of the most extensively studied psychological treatments for panic disorder. Panic-focused protocols usually combine education about panic, examination of catastrophic interpretations, exercises involving feared bodily sensations, and exposure to avoided situations. Their target is not merely general stress but the cycle linking sensations, danger appraisals, fear, and avoidance. Treatment studies commonly assess attack frequency, anticipatory anxiety, agoraphobic avoidance, and functioning rather than relying on a single outcome.
A distinctive component is interoceptive exposure, a form of exposure therapy involving planned contact with feared internal sensations. In clinical protocols, exercises may produce sensations such as a faster heartbeat or dizziness under conditions selected for the individual’s health status. The therapeutic purpose is to change the meaning of those sensations and reduce avoidance, not to establish that every physical symptom is harmless. Contemporary learning accounts emphasize developing new expectations about tolerability and outcomes, rather than requiring anxiety to disappear during each exercise.
Situational exposure addresses activities or environments avoided because of panic-related fears. These can include public transport, shops, crowds, or being away from home. Cognitive work examines predictions such as fainting, losing control, or being unable to escape. Some protocols also address safety behaviors that make exposure appear tolerable only under narrowly controlled circumstances. Breathing retraining and relaxation appear in some treatment packages, but they are not universal requirements, and their contribution varies across protocols.
Evidence from randomized controlled trials supports panic-focused CBT against inactive or minimal-treatment controls. Comparisons with medication and other active treatments are more complex because studies differ in severity, therapist expertise, treatment duration, and definitions of response. A reduction in attacks is not identical to full remission, and short-term success does not guarantee the absence of later recurrence. Follow-up studies indicate that gains can persist after treatment ends, although some participants retain residual symptoms or require further care.
CBT can be delivered individually, in groups, or through structured remote formats. Guided internet-based programs have demonstrated benefit in selected trial populations, but results depend on program content, clinical support, adherence, and participant selection. Other psychotherapies, including panic-focused psychodynamic approaches, have been studied, though the evidence base is smaller. Interpretation of psychotherapy research also requires attention to limitations in blinding, therapist effects, dropout, and the distinction between efficacy in specialist trials and effectiveness in ordinary services.
Pharmacological Treatment and Combined Approaches
Several classes of antidepressants have demonstrated efficacy for panic disorder. Selective serotonin reuptake inhibitors are widely used, as is the serotonin–norepinephrine reuptake inhibitor venlafaxine. Examples with substantial trial evidence include sertraline, paroxetine, and fluoxetine, although regulatory approvals vary by country and formulation. Their use in panic disorder does not imply that the condition is a form of depression; the same medicines can have therapeutic effects across different diagnoses.
Clinical benefit develops over weeks rather than immediately. Early adverse effects can include nausea, sleep disturbance, gastrointestinal symptoms, or a temporary increase in anxiety. Sexual adverse effects and discontinuation symptoms are also relevant to longer-term treatment. The pharmacology of these agents involves altered monoamine signaling, but therapeutic response cannot be taken as proof that panic disorder results from a simple deficiency of serotonin or norepinephrine. Downstream neural adaptation and learning may also contribute to improvement.
Older antidepressants, particularly imipramine and clomipramine, also have evidence of efficacy. Their adverse-effect and safety profiles differ from those of newer agents, including anticholinergic effects, orthostatic hypotension, and greater toxicity in overdose. Monoamine oxidase inhibitors have historical evidence in panic-related conditions but are less commonly used because of interaction risks and treatment complexity. The relative place of these drugs differs across clinical guidelines and health systems.
Benzodiazepines, including alprazolam and clonazepam, can reduce panic symptoms rapidly. Their clinical limitations include sedation, impaired coordination, tolerance, physical dependence, and withdrawal phenomena. Withdrawal can itself produce severe anxiety or panic-like symptoms, complicating the distinction between recurrence and medication effects. Many guidelines therefore restrict their role or do not recommend them for long-term management of panic disorder. Physical dependence is not identical to addiction, although problematic use can also occur.
Combining medication with CBT can improve acute outcomes compared with some single-treatment conditions, but the size and persistence of any added benefit vary across studies. Medication trials also differ in how they handle relapse prevention and discontinuation. Continued treatment after initial response can reduce recurrence during the maintenance period, while stopping medication may be followed by withdrawal symptoms, return of the disorder, or both. Clinical comparisons consequently consider not only symptom relief but also adverse effects, patient preference, comorbid conditions, accessibility, and outcomes after treatment ends. Evidence for some commonly proposed alternatives, such as beta blockers as a primary long-term treatment for panic disorder, is much less established.
Comorbidity, Functional Impairment, and Long-Term Course
Panic disorder commonly co-occurs with other psychiatric conditions. Agoraphobia is especially important, but it is neither inevitable nor required. Affected individuals may also have generalized anxiety disorder, social anxiety disorder, depressive disorders, or substance use disorders. These combinations can alter presentation: a person may report low mood, sleep disruption, alcohol use, or avoidance more prominently than the panic attacks themselves. Diagnostic assessment therefore distinguishes related but independently significant problems rather than treating every symptom as a direct expression of panic.
The relationship with agoraphobia is particularly consequential for functioning. Fear may become organized around public transport, open spaces, enclosed places, queues or crowds, or being outside the home alone. The central concern is difficulty escaping or obtaining help if panic-like or other incapacitating symptoms occur. Severe avoidance can restrict work, study, caregiving, and social contact even when attacks are infrequent. Conversely, panic disorder can cause substantial distress without broad situational avoidance.
Associations with physical illness complicate long-term assessment. Panic symptoms are frequent in some populations with respiratory or cardiovascular disease, and anxiety can intensify the perceived burden of bodily symptoms. Observational studies have also reported associations between panic disorder and later cardiovascular outcomes, but shared risk factors, health behaviors, detection patterns, and other confounding influences limit simple causal conclusions. A psychiatric diagnosis does not invalidate a coexisting medical illness, and a physical diagnosis does not exclude a separate anxiety disorder.
The course is variable rather than uniformly chronic or uniformly self-limited. Some people achieve sustained remission, while others experience residual anticipatory anxiety, intermittent relapses, or persistent avoidance. Attack frequency may decline before confidence and everyday functioning recover. Consequently, health-related quality of life, participation in ordinary activities, and freedom from avoidance can be more informative than counting attacks alone. Long-term studies are affected by differences in treatment exposure, recruitment setting, and how remission is defined.
Suicidal thoughts and behavior occur at elevated rates in populations with anxiety disorders, including panic disorder, particularly when depressive disorders, substance use, or other risk factors are present. This association does not mean that panic disorder alone determines an individual’s risk. Greater baseline severity, extensive agoraphobic avoidance, and psychiatric comorbidity are often associated with more complicated outcomes, although individual trajectories remain difficult to predict. Repeated emergency visits and disrupted employment can add financial and social burdens that persist beyond an acute episode.
Health Services, Measurement, and Research Frontiers
Panic disorder often first presents outside specialist mental health services. People may seek care in emergency departments, cardiology clinics, respiratory services, or primary care because the symptoms feel immediately physical and dangerous. Early encounters can therefore focus on excluding acute medical causes rather than recognizing a recurrent panic pattern. Across later encounters, continuity of information helps distinguish genuinely new clinical features from recurring symptoms without assuming that all future episodes have a psychiatric explanation.
Access to effective care depends on more than the availability of a diagnostic label. The supply of trained therapists, treatment costs, language, stigma, and local prescribing practices influence which interventions are received. Fragmented services may separate medical assessment from psychological treatment even when both are relevant. Integrated and collaborative care approaches have been studied for anxiety disorders, including panic disorder, with attention to systematic symptom monitoring and coordination between primary and specialist services. Their effectiveness depends on the details of the service model and population.
Research outcomes require careful interpretation. “Response” usually refers to a specified degree of improvement, whereas “remission” generally means symptoms falling below a defined threshold; neither term has one universal operational definition across all studies. An attack-free interval does not necessarily indicate recovery from avoidance or anticipatory anxiety. Trials may therefore use structured interviews, severity scales, functional measures, and patient-reported outcomes together. Attrition and short follow-up can make an intervention appear more successful than it is over longer periods.
Biological research seeks more precise explanations of vulnerability and treatment response through genetics, respiratory physiology, and functional magnetic resonance imaging. No clinically established biomarker currently confirms panic disorder or reliably selects the best treatment for a particular person. Brain activation patterns and physiological challenge responses overlap across diagnoses and healthy populations. Small samples, differences in medication exposure, and variation in comorbidity can contribute to inconsistent findings.
Digital assessment offers another line of investigation. Smartphones and wearable devices can record symptom reports, activity, sleep, or heart-rate changes in everyday settings. These data may help characterize the timing of attacks and fluctuations between appointments, but elevated heart rate is not specific to panic, and algorithms trained in selected samples may perform differently elsewhere. Studies also face questions about data privacy, false alarms, and whether repeated monitoring increases bodily vigilance. Establishing clinical usefulness requires evidence that these tools improve meaningful outcomes, rather than merely detecting physiological variation.